Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch 
Australian Scandium Project Backed by Richard Friedland Poised to Support U.S. Critical Minerals Stockpile 
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised 
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off 
Instagram Outage Disrupts Thousands of U.S. Users 
AMD Shares Slide Despite Earnings Beat as Cautious Revenue Outlook Weighs on Stock 
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering 
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks 
Ford and Geely Explore Strategic Manufacturing Partnership in Europe 
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026 
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate 
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings 
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences 
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment 
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans 
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit 
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO 
LOS ANGELES, Sept. 11, 2017 -- Levine Leichtman Capital Partners (“LLCP”), a Los Angeles-based private equity firm, announced that it has partnered with management to acquire Capsa Healthcare (“Capsa” or the “Company”). Capsa is a leading provider of mobile workstations, medication management products, and pharmacy automation solutions for healthcare settings worldwide. The Company’s workflow solutions increase efficiency for over 3,000 customers, including leading health systems, senior care communities and major retail and institutional pharmacies. Capsa is headquartered in Portland, OR and has additional production facilities in Columbus, OH and Agua Prieta, Mexico.
The investment in Capsa will be the first investment from Levine Leichtman Capital Partners VI, L.P. According to Aaron Perlmutter, Partner of LLCP, “We are excited to partner with Andrew Sherrill, CEO, and the rest of the Capsa management team, who have successfully built a market leading company in an attractive segment of the healthcare industry. We are looking forward to working with Andrew and his team to continue providing innovative solutions to a growing and evolving healthcare landscape.”
The Company’s management team, led by Andrew Sherrill, will acquire a meaningful ownership stake in the Company in connection with the transaction. Andrew Sherrill commented, “My team and I are very excited to partner with LLCP as Capsa seeks to enhance its market-leading position across the healthcare ecosystem. LLCP’s experience across sectors including highly-engineered products and healthcare services – the intersection of which Capsa is situated – as well as LLCP’s operational and deal origination resources, will be critical to the continued growth of the Company.”
LLCP was advised by Kirkland & Ellis LLP. Senior financing was provided by Midcap Financial, NewStar Financial and Madison Capital.
About Levine Leichtman Capital Partners
LLCP is a Los Angeles, California based private investment firm that has managed approximately $9.0 billion of institutional capital since its inception. LLCP invests in middle market companies located in the United States and Europe. LLCP is currently making new investments through Levine Leichtman Capital Partners VI, L.P., LLCP Lower Middle Market Fund, L.P., Levine Leichtman Capital Partners Private Capital Solutions, L.P., Levine Leichtman Capital Partners Europe, L.P. and LLCP Co-Investment Fund, L.P. LLCP has offices in Los Angeles, New York, Dallas, Chicago, London and The Hague.
Contact: David Wolmer
Phone: 310-275-5335
